Back to results
US 2003/0153756 A1Published application
Pyrimido[5,4-e] [1,2,4]triazine-5, 7-diamine compounds as protein tyrosine phosphatase inhibitors
AssigneeHoffman-La Roche Inc.
InventorsKevin Richard Guertin, Lina Quattrocchio Setti
Life of this patent
Estimating the term…
Abstract
The invention relates to pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds which are useful for inhibiting protein tyrosine phosphatases, particularly PTP1B.
Claims17
A compound of the formula:
- 32
- wherein
- R1 and R2 are individually selected from the group consisting of hydrogen, or
- R1 and R2 together form a bond, —CH2—, —O—, —NH— or —N—R3,
- R3 is lower alkyl or —CH2—Ar, and
- Ar is selected from the group consisting of unsubstituted phenyl;
- unsubstituted naphthyl;
- phenyl mono- or bi-substituted with lower alkyl, lower alkoxy, aryl, cycloalkyl, lower alkyl-aryl, lower alkoxy-aryl, lower alkyl-cycloalkyl, lower alkoxy-cycloalkyl, halo, cyano or trifluoromethyl;
- and naphthyl mono- or bi-substituted with lower alkyl, lower alkoxy, aryl, cycloalkyl, lower alkyl-aryl, lower alkoxy-aryl, lower alkyl-cycloalkyl, lower alkoxy-cylcoalkyl or halo;
- or pharmaceutically acceptable salts thereof.
7 more elements
Dependencies are inferred from the claim text.